CASTLE BIOSCIENCES INC - Common Stock (CSTL)

Q1 2025 13F Holders as of 3/31/2025

Type / Class
Equity / Common Stock
Shares outstanding
28.9M
Number of holders
180
Total 13F shares, excl. options
25.8M
Shares change
-639K
Total reported value, excl. options
$516M
Value change
-$22.6M
Put/Call ratio
0.53
Number of buys
104
Number of sells
-96
Price
$20.02

Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q1 2025

232 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q1 2025.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25.8M shares of 28.9M outstanding shares and own 89.21% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.98M shares), VANGUARD GROUP INC (2.05M shares), PRINCIPAL FINANCIAL GROUP INC (1.47M shares), Portolan Capital Management, LLC (1.27M shares), DIMENSIONAL FUND ADVISORS LP (1.2M shares), WASATCH ADVISORS LP (998K shares), WELLINGTON MANAGEMENT GROUP LLP (829K shares), STATE STREET CORP (715K shares), RENAISSANCE TECHNOLOGIES LLC (701K shares), and ACADIAN ASSET MANAGEMENT LLC (676K shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.